Scalp Psoriasis: Causes, Treatments, and What Actually Clears It

What Makes Scalp Psoriasis Different

Psoriasis on the scalp follows the same immunological pathway as plaque psoriasis on the body: overactive T-helper 17 (Th17) cells produce interleukin-17 (IL-17) and interleukin-23 (IL-23), triggering keratinocyte hyperproliferation and the characteristic scaling plaques [1]. But the scalp adds complexity. Hair makes topical application harder. The skin barrier is different. And the psychosocial impact of visible flaking in the hair and on clothing often outweighs what the disease severity scores would suggest.

The scalp is the most common site of psoriasis involvement. In a study of over 5,600 psoriasis patients, scalp involvement was reported in 79% of cases, making it more common than involvement of elbows, knees, or trunk [2].

What Causes Scalp Psoriasis to Flare

The same triggers that drive psoriasis elsewhere apply to the scalp, but some are more relevant:

• Koebner phenomenon: Physical trauma to the scalp (scratching, harsh brushing, tight hairstyles) can trigger new plaques in previously unaffected areas [3]
• Stress: Psychological stress is the most commonly reported trigger, activating the hypothalamic-pituitary-adrenal axis and increasing pro-inflammatory cytokine release
• Cold, dry weather: Low humidity reduces skin hydration and increases scaling
• Infections: Streptococcal pharyngitis is a well-documented trigger, particularly for guttate psoriasis that can involve the scalp
• Hair products: Alcohol-based styling products, harsh sulfate shampoos, and chemical treatments can irritate plaques

How to Tell It Apart from Dandruff and Seborrheic Dermatitis

Scalp psoriasis is frequently misdiagnosed as severe dandruff or seborrheic dermatitis. The distinction matters because treatment approaches differ.

When in doubt, a dermatologist can biopsy a plaque for definitive diagnosis. The histological pattern of psoriasis (acanthosis, parakeratosis, Munro microabscesses) is distinctive.

First-Line Treatments: Topicals

Topical Corticosteroids

High-potency topical corticosteroids (clobetasol propionate 0.05%, betamethasone dipropionate) are the most effective first-line therapy for scalp psoriasis. Solutions, foams, and sprays are preferred over creams and ointments because they penetrate through hair more effectively [4].

A typical protocol:

• Apply high-potency steroid solution to affected areas once daily for 2-4 weeks
• Taper to every other day or twice weekly for maintenance
• Take periodic breaks (2 weeks on, 1 week off) to reduce atrophy risk

Response rates are good: approximately 70-80% of patients achieve marked improvement within 4 weeks. The limitation is relapse after discontinuation. Most patients need ongoing intermittent use.

Calcipotriol (Vitamin D Analog)

Calcipotriol (calcipotriene) slows keratinocyte proliferation and promotes differentiation. It is less potent than corticosteroids as monotherapy but works well as a steroid-sparing agent for maintenance. The combination of calcipotriol + betamethasone dipropionate (Enstilar foam, Taclonex) is one of the most effective topical options available, outperforming either agent alone in head-to-head trials [5].

Coal Tar Preparations

Coal tar has been used for psoriasis for over a century. It suppresses DNA synthesis and has anti-inflammatory properties. Modern formulations are cosmetically acceptable: shampoos containing 0.5-5% coal tar (Neutrogena T/Gel, MG217) can be used 2-3 times weekly as maintenance therapy. The evidence supports coal tar as a useful adjunct, though it is less effective than corticosteroids for active flares [6].

Salicylic Acid (Keratolytic)

Thick scale prevents topical medications from reaching the skin. Salicylic acid (3-6%) works as a keratolytic, softening and removing scale to improve penetration of active treatments. It is best used as a pre-treatment step: apply salicylic acid shampoo or solution, leave for 10-15 minutes, then rinse and apply the active medication.

Medicated Shampoo Protocol

For mild to moderate scalp psoriasis, a structured shampoo protocol can manage symptoms effectively:

1. Descaling wash (2-3x/week): Salicylic acid 3% shampoo. Lather, leave 10 minutes, rinse.
2. Therapeutic wash (2-3x/week, alternating): Coal tar or ketoconazole 2% shampoo. Lather, leave 5-10 minutes, rinse.
3. Spot treatment (daily as needed): Clobetasol solution or calcipotriol/betamethasone foam to active plaques.
4. Gentle days: Sulfate-free, fragrance-free shampoo on non-treatment days.

The key is consistency. Scalp psoriasis responds to sustained treatment over weeks, not one-time applications.

Phototherapy for Scalp Psoriasis

Narrowband UVB phototherapy is effective for scalp psoriasis but delivery is complicated by hair coverage. Options include:

• Handheld UV combs: Designed to part hair and deliver UVB directly to the scalp. Used 3-5 times weekly for 8-12 weeks.
• Excimer laser (308 nm): Targeted UVB delivery to individual plaques. Effective for localized disease.
• Full-body phototherapy: Treats scalp incidentally when used for widespread psoriasis.

A 2019 systematic review found that UV comb therapy achieved PASI 75 in 60-80% of patients with scalp-predominant psoriasis [7]. It is underused, partly because home devices require a prescription and insurance coverage is inconsistent.

Systemic and Biologic Therapies

When topical treatments fail to control scalp psoriasis, systemic therapies become necessary. The scalp responds to the same biologics and oral agents used for body psoriasis:

Biologics

• IL-17 inhibitors (secukinumab, ixekizumab, brodalumab): Among the most effective for scalp-specific psoriasis. Ixekizumab achieved scalp-specific PASI 100 (complete clearance) in 75% of patients at 12 weeks in the IXORA-S trial [8].
• IL-23 inhibitors (guselkumab, risankizumab, tildrakizumab): Strong efficacy with less frequent dosing (every 8-12 weeks after loading).
• TNF inhibitors (adalimumab, etanercept): Effective but generally lower scalp clearance rates than IL-17/IL-23 inhibitors.

Oral Systemic Agents

• Apremilast (Otezla): PDE4 inhibitor with modest efficacy for scalp psoriasis. Better tolerated than methotrexate but less effective than biologics.
• Methotrexate: Effective for moderate-to-severe psoriasis. Weekly dosing. Requires liver and blood count monitoring.
• Cyclosporine: Rapid-acting but limited to short courses (3-6 months) due to nephrotoxicity risk.

What About Natural Approaches?

Patients frequently ask about natural treatments. The evidence is limited but some approaches show promise:

• Aloe vera: A small RCT showed topical aloe vera cream improved PASI scores compared to placebo. Effect size was modest [9].
• Tea tree oil: Has anti-inflammatory and antimicrobial properties. Some patients report reduced itching and scaling. No large controlled trials exist specifically for scalp psoriasis.
• Omega-3 supplementation: A meta-analysis found mild benefit for psoriasis severity, likely through anti-inflammatory EPA/DHA pathways [10]. Not sufficient as monotherapy but may reduce flare frequency.
• Dead Sea salt soaks: Difficult to apply to the scalp specifically, but Dead Sea climatotherapy has documented benefit for psoriasis generally.

Natural approaches work best as adjuncts to evidence-based therapies, not replacements.

Hair Loss and Scalp Psoriasis

Scalp psoriasis itself does not cause permanent hair loss. The hair loss that occurs is temporary and related to the inflammatory process and physical disruption of the hair follicle by thick plaques. Aggressive scratching and picking at scales causes the most hair damage.

Once inflammation is controlled, hair regrows in most cases. Permanent scarring alopecia from scalp psoriasis is rare and typically only occurs in severe, long-untreated cases.

Building a Long-Term Management Plan

Scalp psoriasis is chronic. The goal is sustained control with minimal medication burden:

1. Start with topical corticosteroids + calcipotriol for active flares (4-8 weeks)
2. Transition to maintenance: medicated shampoos 2-3x/week + intermittent topical steroids
3. If topicals fail after 12 weeks of consistent use, discuss phototherapy or systemic options
4. Address triggers: stress management, gentle hair care, humidification in dry climates
5. Monitor and adjust quarterly with your dermatologist

Related Reading

• Psoriasis: The Evidence-Based Guide (Pillar)
• Psoriasis Diet: Foods That Help, Foods That Trigger Flares
• Psoriasis Treatment Options: Biologics, Topicals, Light Therapy

References

1. Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227-255. doi:10.1146/annurev-immunol-032713-120225
2. Merola JF, Li T, Li WQ, et al. Prevalence of psoriasis phenotypes among men and women in the USA. Clin Exp Dermatol. 2016;41(5):486-489. doi:10.1111/ced.12805
3. Koebner H. Zur aetiologie der psoriasis. Vjschr Dermatol. 1876;8:559-561.
4. Schlager JG, Rosumeck S, Werner RN, et al. Topical treatments for scalp psoriasis: summary of a Cochrane Systematic Review. Br J Dermatol. 2017;176(3):604-614. doi:10.1111/bjd.14800
5. Kragballe K, Austad J, Barnes L, et al. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product in the treatment of psoriasis vulgaris. Br J Dermatol. 2006;154(6):1155-1160. doi:10.1111/j.1365-2133.2006.07231.x
6. Roelofzen JH, Aben KK, Oldenhof UT, et al. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. J Invest Dermatol. 2010;130(4):953-961. doi:10.1038/jid.2009.389
7. Almutawa F, Alnomair N, Wang Y, et al. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol. 2013;14(2):87-109. doi:10.1007/s40257-013-0015-y
8. Reich K, Pinter A, Engel A, et al. Ixekizumab for scalp psoriasis: results from the IXORA-S study. J Dermatol Treat. 2020;31(5):474-479. doi:10.1080/09546634.2019.1607556
9. Choonhakarn C, Busaracome P, Sripanidkulchai B, et al. A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis. J Eur Acad Dermatol Venereol. 2010;24(2):168-172. doi:10.1111/j.1468-3083.2009.03377.x
10. Clark CCT, Taghizadeh M, Nahavandi M, et al. Efficacy of omega-3 supplementation in patients with psoriasis: a meta-analysis of randomized controlled trials. Clin Rheumatol. 2019;38(4):977-988. doi:10.1007/s10067-019-04456-x